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ABSTRACT The Guiana extended-spectrum (GES) b-lactamase GESG170H, GESG170L,
and GESG170K mutants showed kcat, Km, and kcat/Km values very dissimilar to those of
GES-1 and GES-5. The enhancement of the hydrolytic activity against carbapenems is
potentially due to a shift of the substrate in the active site that provides better posi-
tioning of the deacylating water molecule caused by the presence of the imidazole
ring of H170 and of the long side chain of K170 and L170.
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Guiana extended-spectrum (GES) b-lactamases have been discovered in a large va-riety of Gram-negative bacterial species (1, 2). At the time of writing, 42 different
variants of GES-1 have been identified (https://www.ncbi.nlm.nih.gov/pathogens/isolates
#/refgene/GES), and some of them have been described as carbapenemases (i.e., GES-2,
GES-4, GES-5, GES-6, GES-14, GES-16, GES-18, and GES-20) (3, 4). The first GES b-lacta-
mase, GES-1, has a glycine at position 170, whereas GES variants, classified as carbapene-
mases, have a residue of serine (G170S) or asparagine (G170N). Several studies demon-
strated that a detectable carbapenemase activity is correlated with the role of residue
170 (Ambler numbering scheme), which belongs to the X-loop (5–7). Nevertheless, there
are some GES variants, such as GES-13, which, despite having the natural mutation
G170N, showed a weak activity against carbapenems (8). Most of the GES variants are
susceptible to classical b-lactamase inhibitors, such as tazobactam and clavulanic acid
(9). In the most common class A b-lactamases, position 170 is occupied by asparagine
(i.e., TEM, SHV, KPC, CTX-M, SME, NMCA, and some GES types), glycine/serine (some GES
types), or histidine (PER and VEB). The aim of the present study was to investigate the
role of residue 170 in GES-1, when glycine is replaced by histidine (H), leucine (L), and ly-
sine (K). In particular, our intent was to evaluate the evolution of carbapenemase activity
in these variants. In this context, in silico modeling simulations have been performed to
evaluate the interactions of these residues with imipenem.
blaGESG170H, blaGESG170L, and blaGESG170K mutants were generated by site-saturation muta-
genesis using pET-24-GES-1 plasmid as the template (10). Mutated bla genes, including sig-
nal peptide, were cloned into pET-24a(1) vector, and the recombinant plasmids were trans-
ferred in Escherichia coli BL21(DE3) for protein expression. Recombinant clones were grown
in the presence of cefotaxime (4mg/liter). Among the selected clones, only the crude
extracts of three of them (E. coli/pET-24-GESG170H, E. coli/pET-24-GESG170L, and E. coli/pET-24-
GESG170K) showed a significant activity against carbapenems. The three GES-1 mutants were
purified as previously described (10). Antimicrobial susceptibilities were determined by con-
ventional broth microdilution procedures, as suggested by the Clinical and Laboratory
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Standard Institute (CLSI), using a bacterial inoculum of 5 105 CFU/ml (11). IPTG (isopropyl-
b-D-thiogalactopyranoside) was added to the cation-adjusted Mueller-Hinton broth
(CAMHB), used for the MIC assay, at a concentration of 0.4mM. The MICs for E. coli/pET-24-
GESG170H, E. coli/pET-24-GESG170L, and E. coli/pET-24-GESG170K were compared with those of E.
coli/pET-24-GES-1 and E. coli/pET-24-GES-5. The MIC results are shown in Table 1. The combi-
nation piperacillin-tazobactam was able to reduce MIC values of piperacillin in all strains
(MICs ranging from 2mg/liter to 16mg/liter) to a susceptible level. Clavulanic acid brought a
decrease in MIC values for amoxicillin to an intermediate level in E. coli/pET-24-GES-1 and E.
coli/pET-24-GES-5 and to a susceptible level in E. coli/pET-24-GESG170L and E. coli/pET-24-
GESG170K, while in E. coli/pET-24-GESG170H, the MIC value of 128mg/liter was unchanged. GES-
1, GESG170H, GESG170L, and GESG170K conferred a susceptible phenotypic profile to E. coli BL21
(DE3) against cefoxitin, with MICs ranging from 2mg/liter to 8mg/liter, while GES-5 showed
an intermediate value of 16mg/liter. All recombinant strains were resistant to cefotaxime,
with MIC values of $4mg/liter. E. coli/pET-24-GES-1 and E. coli/pET-24-GES-5 were resistant
to cefazolin (MIC of .128mg/liter), whereas the mutant strains showed susceptibility to
cefazolin. Intermediate MIC values for meropenem and ertapenem were determined for E.
coli/pET-24-GESG170H and E. coli/pET-24-GESG170L, and susceptible values were found for E.
coli/pET-24-GESG170K, as for E. coli harboring GES-1 and GES-5.
Steady-state kinetic experiments were carried out at 25°C in 20mM sodium phosphate
buffer (pH 7.0), containing 0.2 M KCl to prevent enzyme instability. The substrate hydrolysis
was monitored by using a Perkin-Elmer Lambda 25 spectrophotometer (Perkin-Elmer
Italia, Monza, Italy). Each kinetic value is the mean of three different measurements; the
error was below 10%. Kinetic parameters were determined under initial-rate conditions
using Origin Pro 8.5.1 to generate Michaelis-Menten curves. For Km values lower than
25mM and higher than 1mM, Km was determined as the inhibitor constant (Ki), using nitro-
cefin as the reporter substrate (12). Inhibition experiments with clavulanic acid and tazo-
bactam were monitored directly by using nitrocefin as the reporter substrate. Competitive
inhibition assays were performed using the equation v0/vi = 1 1 [(Km  I)/(Km 1 S)  Ki],
where vi and v0 represent the initial rates of hydrolysis of nitrocefin with and without inhib-
itor, respectively, I is the concentration of inhibitor or poor substrate, Ki is the inhibition
constant, Km is the Michaelis constant, and S is the concentration of the reporter substrate.
The plot v0/vi versus I yielded a straight line of slope: Km/(Km 1 S)  Ki (12, 13).
In compounds behaving as transient inhibitors, accumulation and slow hydrolysis
of EC* were studied on the basis of the model
E1C  !
Kd
E  C!k12 EC !k13 Eþ P
where E is enzyme, C is substrate, E·C is the Henri-Michaelis complex, EC* is the acyl-
enzyme complex, and P is the hydrolysis product. k12 and k13 are the first-order
TABLE 1 b-Lactam susceptibility of E. coli BL21(DE3) strains carrying blaGES-1, blaGES-5, blaGESG170H, blaGESG170L, and blaGESG170K genes
b-Lactam(s)a
MIC (mg/liter) for E. coli BL21(DE3) strain carrying plasmidb:
pET-24/GES-1 pET-24/GES-5 pET-24/GES-1G170H pET-24/GES-1G170L pET-24/GES-1G170K pET-24
Piperacillin .512 .512 512 .512 .512 1
Piperacillin-tazobactam 8 8 16 2 2 1
Amoxicillin .512 .512 128 64 64 0.5
Amoxicillin-clavulanic acid 16 16 128 1 1 0.5
Imipenem 1 4 4 1 0.25 0.0625
Ertapenem 0.0625 0.5 1 1 0.5 0.0625
Meropenem 0.0625 1 2 2 1 0.0625
Cefazolin .128 .128 8 16 8 0.125
Cefoxitin 2 16 4 8 2 0.125
Cefotaxime 16 4 8 8 8 0.0625
aTazobactam was used at fixed concentration of 4mg/liter, and the amoxicillin-clavulanic acid combination was used at a ratio of 2:1.
bMICs were determined on microdilution plates using an inoculum of 5 105 CFU/ml as reported by CLSI (11). The experiments were performed in triplicate. The analysis of
the obtained data was carried out as suggested by CLSI (19).
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acylation and deacylation constants, respectively. Kd is the dissociation constant of
Henry-Michaelis complex. In the case of poor substrates, the values of ki (the first-order
rate constant characterizing the EC* accumulation) were obtained by time course hy-
drolysis of nitrocefin according to equations 1 and 2, as previously reported (12):
ðvt 2 vssÞ=ðv0 2 vssÞ ¼ e2kit (1)
v0, vt, and vss, respectively, are the rate transformation of substrate at time zero, time t,
and steady state:
ki ¼ k13 1 k12 C
½ 
C½ 1K 11 S½ =Km S
  (2)
Steady-state kinetic constants (Km and kcat) were calculated for GESG170H, GESG170L, and
GESG170K and compared to those of GES-1 and GES-5 toward selected b-lactams (Table 2).
Imipenem. Surprisingly, GESG170H exhibited a kcat value for imipenem of 3 s21, approxi-
mately 4- and 500-fold higher than those of GES-5 and GES-1, respectively. The kcat for imipe-
nem calculated for GESG170L was slightly less than that of GES-5 but 3-fold higher than that
of GES-1. Instead, the kcat for GESG170K was comparable to that of GES-1. Km values for
GESG170H and GESG170L were 24 and 25mM, respectively, and unlike other GES enzymes, were
determined by following direct hydrolysis of substrate. The kcat/Km values calculated for the
three mutants were comparable to that of GES-1 and lower than that of GES-5.
Meropenem. Meropenem was well hydrolyzed by GESG170H and GESG170L, with kcat
values of 10 s21 and 6 s21, respectively. Instead, GESG170K exhibited a lower kcat value
(0.35 s21), similar to that calculated for GES-5 but at least 50-fold higher than that for
GES-1. With the exception of GESG170H, GESG170L and GESG170K showed the same Km
value as GES-1 (0.08mM). GESG170H exhibited a Km value of 40mM, which was measured
by direct hydrolysis of meropenem. The catalytic efficiency values calculated for the
three mutants were higher than those for GES-1 and, with the exception of GESG170H,
also higher than those for GES-5. In particular, GESG170L exhibited kcat/Km values 150-
and 862-fold higher than those for GES-5 and GES-1, respectively.
Ertapenem. GESG170H, GESG170L, and GESG170K hydrolyzed ertapenem better than
GES-1 and GES-5, with a behavior similar to that found for meropenem. GESG170H
hydrolyzed ertapenem more efficiently than GESG170L and GESG170K. However, due to
the higher Km value (10mM), GESG170H showed a kcat/Km value lower than those of
GESG170L and GESG170K. In GESG170H, the Km value is probably affected by the presence of
a bulky and partially ionized imidazole ring. The histidine 170 was also found in PER
variants, and the b-lactam kinetic profiles of PER-7 and PER-8 showed that PER
enzymes, unlike the main ESBLs, are able to efficiently hydrolyze imipenem (14).
Penicillins. For benzylpenicillin, Km values for GESG170H, GESG170K, and GESG170L were
31, 6, and 0.07mM, respectively. Compared to GES-1 and GES-5, the three mutants
showed a drastic decrease in kcat values. In detail, GESG170H and GESG170L exhibited kcat
values approximately 20- and 292-fold lower than that of GES-1 and 42- and 635-fold
lower than that of GES-5, respectively. Benzylpenicillin behaved as a poor substrate for
the GESG170K mutant, showing a low Km value (6mM) calculated as Ki. However, kinetic
inhibition experiments to ascertain whether benzylpenicillin behaved as a transient
inactivator were performed using kinetic models and equations previously reported
(12, 13). The variation of ki versus benzylpenicillin concentration was linear. We could
then compute the values of the deacylation constant (k13 = 0.014 s21) and the second-
order acylation constant (k12/Kd = 0.6 1023mM21 s21). Because of the lower Km value,
GESG170L showed kcat/Km ratios 10- and 7- fold higher than those of GES-1 and GES-5,
respectively. In comparison to GES-5 and GES-1, the three mutants showed very low Km
values, calculated, as for the other penicillins, using nitrocefin as a reporter substrate.
The hydrolytic activity was drastically reduced in the three mutants. GESG170H and
GESG170L showed kcat/Km values higher than those of both GES-1 and GES-5, essentially
due to low Km values. A drastic decrease in Km and kcat values was also observed for
GESG170H, GESG170K, and GESG170L compared to GES-1 and GES-5. However, among the
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TABLE 2 Determination of kinetic constants of GESG170H, GESG170L, and GESG170K compared to GES-1 and GES-5a
Substrate Variantb Km (mM) kcat (s21) kcat/Km (mM21 s21)
kcat/Km ratio of:
GESmut/GES-5 GESmut/GES-1
Imipenem GES-1 0.86 0.1 0.0066 0.001 0.0076 0.002 0.004 1
GES-5 0.46 0.1 0.76 0.1 1.756 0.7 1 250
GESG170H 246 2 36 0.5 0.126 0.03 0.07 17
GESG170L 256 3 0.26 0.02 0.0086 0.0017 0.004 1.1
GESG170K 0.0096 0.001 0.0086 0.001 0.896 0.21 0.05 127
Meropenem GES-1 0.086 0.01 0.0076 0.001 0.0876 0.023 0.17 1
GES-5 0.36 0.02 0.156 0.01 0.506 0.067 1 5.7
GESG170H 406 3 106 0.5 0.256 0.031 0.5 2.9
GESG170L 0.086 0.01 66 0.5 75.006 15.6 150 862
GESG170K 0.086 0.01 0.356 0.02 4.376 0.79 8.7 50
Ertapenem GES-1 0.256 0.02 0.0036 0.0005 0.016 0.025 0.025 1
GES-5 0.266 0.01 0.16 0.01 0.386 0.053 1 38
GESG170H 106 1 66 0.2 0.606 0.08 1.6 60
GESG170L 0.316 0.1 2.56 0.05 8.16 2.77 21 810
GESG170K 0.116 0.01 0.26 0.02 1.86 0.34 4.7 180
Benzylpenicillin GES-1 2106 15 1176 5 0.566 0.064 0.7 1
GES-5 3106 20 2546 2 0.826 0.059 1 1.5
GESG170H 316 2c 66 0.2 0.196 0.018 0.23 0.34
GESG170L 0.076 0.01 0.46 0.02 5.716 1.1 7 10
GESG170K 66 0.5c 0.0146 0.001d 0.00066 0.0009e 0.0007 0.001
Ampicillin GES-1 2606 20 2636 3 1.016 0.089 3 1
GES-5 1486 12 536 1 0.366 0.036 1 0.36
GESG170H 16 0.05c 46 0.1 4.006 0.3 11.1 4
GESG170L 0.46 0.03c 0.86 0.02 2.006 0.2 5.5 2
GESG170K 46 0.5c 16 0.05 0.256 0.044 0.7 0.25
Piperacillin GES-1 1,4006 150 1846 2 0.136 0.015 6.5 1
GES-5 .3,000 .58 NDf — —
GESG170H 86 0.5c 236 1 2.876 0.3 143 22
GESG170L 0.46 0.05c 16 0.05 2.506 0.44 125 19
GESG170K 156 1.2c 0.56 0.05 0.036 0.054 1.5 0.23
Carbenicillin GES-1 1,2506 35 416 2 0.036 0.002 6 1
GES-5 .3,000 .16 ND —h —
GESG170H 4856 15 86 1 0.026 0.003 — 0.67
GESG170L 26 0.5c 106 1 5.006 1.75 — 167
GESG170K 236 1c 16 0.05 0.506 0.047 — 16.7
Cefazolin GES-1 1,4406 35 3756 3 0.266 0.008 0.15 1
GES-5 5006 20 8446 2 1.696 0.072 1 6.5
GESG170H 356 3 96 1 0.266 0.05 0.15 1
GESG170L 1176 2 586 2 0.496 0.025 0.29 1.9
GESG170K 866 8 56 0.2 0.066 0.008 0.035 0.23
Cefoxitin GES-1 506 5 NHg ND — —
GES-5 3806 20 306 0.2 0.086 0.006 1 —
GESG170H 226 2 0.76 0.1 0.036 0.007 0.375 —
GESG170L 36 0.5c 86 1 2.676 0.78 33 —
GESG170K 26 0.6c NH ND — —
Cefotaxime GES-1 12,0006 150c .119 ND — —
GES-5 9,6006 220c .10 ND — —
GESG170H 9106 80 146 1 0.0156 0.002 — —
GESG170L 1026 8 56 0.1 4.176 0.41 — —
GESG170K 56 0.4c 16 0.03 0.206 0.02 — —
(Continued on next page)
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three mutants, GESG170H hydrolyzed piperacillin better than GESG170K and GESG170L,
even if its kcat/Km value is similar to that calculated for GESG170L. The three GES mutants
have Km and kcat values lower than those calculated for GES-1 and GES-5. Unlike
GESG170L and GESG170K, GESG170H showed a Km value of 485mM, which was calculated by
measuring direct hydrolysis of substrate. With the exception of GESG170H, GES mutants
showed kcat/Km values higher than those for GES-1.
Cephalosporins. GESG170H, GESG170L, and GESG170K mutants showed a decrease in
kcat and Km values toward cefazolin, cefotaxime, and cefoxitin. Cefoxitin was a poor sub-
strate for GESG170H, which showed a kcat of 0.7 s21 and was not hydrolyzed by GESG170K.
Unlike GES-1, GES-5, and GESG170K, Km values for GESG170H and GESG170L were calculated
by direct hydrolysis of cefotaxime.
In the current study, position 170 has also been studied in relation to interaction
with inhibitors. Indeed, the residue 170 in GES enzymes plays an important role in the
inhibition by clavulanic acid (9). Inhibition experiments with clavulanic acid and tazo-
bactam were monitored directly by using nitrocefin as the reporter substrate (12).
Tazobactam and clavulanic acid behaved as competitive inhibitors for GES-1, GES-5,
GESG170K, GESG170H, and GESG170L. Tazobactam and clavulanic acid were able to inhibit
efficiently GESG170L and GESG170K, with Ki and 50% inhibitory concentration (IC50) values
lower than those calculated for GES-1 and GES-5 (Table 3). On the contrary, GESG170H
exhibited an increase in Ki values for both tazobactam and clavulanic acid. In particular,
a very high Ki value was calculated for clavulanic acid (.200 mM). The same behavior
has been reported for GES-4, where the IC50s for clavulanic acid and tazobactam were
similar to those calculated for classical inhibitor-resistant TEM b-lactamases (IRT) (15).
In order to explain the effect of G170L, G170K, and G170H substitutions on sub-
strate hydrolysis, molecular modeling was performed using the 1.1-Å resolution X-ray
structure of GES-1 (Protein Data Bank code 2QPN) as the template (16). Initial attempts
TABLE 2 (Continued)
Substrate Variantb Km (mM) kcat (s21) kcat/Km (mM21 s21)
kcat/Km ratio of:
GESmut/GES-5 GESmut/GES-1
Nitrocefin GES-1 3306 15 1686 2 0.516 0.029 0.11 1
GES-5 1706 12 7696 3 4.526 0.34 1 8.9
GESG170H 1276 6 96 0.2 0.076 0.005 0.015 0.14
GESG170L 916 7 86 0.6 0.096 0.014 0.005 0.18
GESG170K 1716 10 16 0.05 0.0066 0.0006 0.001 0.01
aEach kinetic value is the mean of three different measurements; the error was below 10%. Kinetic parameters were determined under initial-rate conditions using Origin
Pro 8.5.1 to generate Michaelis-Menten curves. For Km values lower than 25mM and higher than 1mM, Km was determined as ki using nitrocefin as the reporter substrate.
bFor each substrate shown, data for GES-1 and GES-5 are from Piccirilli et al. (10).
cKm was calculated as Ki, using nitrocefin as the reporter substrate (12).
dCalculated as k13 (Ki values as a function of substrate concentration) (12).
eCalculated as k12/K (Ki values as a function of substrate concentration) (12).
fND, not determined.
gNH, no hydrolysis.
h—, not possible to calculate.




Ki (mM) IC50 (mM) Ki (mM) IC50 (mM)
GES-1 216 1 386 2 2.06 0.5 3.56 0.5
GES-5 176 1 156 1 1.76 0.2 2.06 0.5
GESG170L 86 1 156 1 0.0486 0.01 0.066 0.01
GESG170K 76 1 136 1 0.256 0.05 0.36 0.05
GESG170H .200 .200 106 1 186 1
aKi and IC50 were determined using nitrocefin as the reporter substrate at the following concentrations: 200, 100,
90, 80, and 100mM for GES-1, GES-5, GESG170H, GESG170L, and GESG170K, respectively.
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to obtain the three models using mutations and rotamer selection in PyMOL (The
PyMOL Molecular Graphics System, Version 2.3.2, Schrödinger, LLC.) followed by the
energy minimization procedure implemented in YASARA (version 17.1.28; YASARA
Biosciences GmbH) (17) produced an unrealistic displacement of the b-strand contain-
ing the third conserved motif that significantly enlarged the active site, as revealed by
the model of the GESG170S mutant reminiscent of GES-5, for which a high-resolution
crystallographic structure is also available. The use of the homology modeling proce-
dure of the YASARA software still using 2QPN as the starting model (with the catalytic
water molecule as part of the template) yielded models of the GESG170H, GESG170L, and
GESG170K mutants with no unrealistic region detected. As shown in Fig. 1a to c, the
three mutations did not induce any significant alteration of the position of the catalytic
site residues compared to GES-1, which is also very similar to GES-5. The root mean
square deviation (RMSD) for all Ca carbons is below 0.1 Å compared to GES-1. When
considering all atoms of the conserved catalytic residues (SxxK, SxN, KTG, and E166),
FIG 1 Models of the GESG170H, GESG170K, and GESG170L mutants. (a) Superimposition of the GES-1 structure
(PDB code 2QPN) in white and the GESG170H model in magenta represented as a cartoon. Important active
site residues are represented as sticks. The catalytic water molecule is shown as a small red sphere, and
black dashed lines highlight its polar contacts. (b) Same as panel a for the GESG170K model in cyan. (c) Same
as panel a for the GESG170L model in yellow. (d) Superimposition of the GES-1 structure in complex with
imipenem (PDB code 4GOG) in white (imipenem as gray sticks) and the GESG170H corresponding model in
magenta (imipenem as orange sticks) represented as a cartoon. Important active site residues are
represented as sticks and the catalytic water molecule by a small red sphere. (e) Same as panel d for the
GESG170K model in cyan. (f) Same as panel d for the GESG170L model in yellow. (g) GES-1 structure represented
as transparent surface surrounding the mixed cartoon and stick representation of panel a; the catalytic water
molecule is shown as a red sphere, and the imipenem molecule from the superposed GESG170L model is
represented as orange sticks. (The GES-1:imipenem structure could not be used because of the absence of a
properly positioned catalytic molecule.) (h) Same as panel g. For the GESG170L model, the catalytic water
molecule is shielded by L170.
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the RMSD is below 0.52 Å, further highlighting the lack of significant modification to
the structure, including in the X-loop that contains the mutations (Fig. 1a to c). In addi-
tion to the low RMSD values compared to 2QPN, the overall Z-scores for the GESG170H,
GESG170L, and GESG170K models were, respectively, 0.684, 0.635, and 0.659 (the positive
values indicating the X-ray-like quality of the model), indicating that the quality pres-
ent in the starting modeled was conserved. To evaluate the influence of a substrate
on these models, we superimposed the GES-1:imipenem acyl-enzyme structure (PDB
code 4GOG) on the models, copied the coordinates of the imipenem molecule in the
acyl-enzyme form into the pdb files of the models (with the catalytic water molecule
remaining part of the model), created a covalent bond between imipenem and S70,
and used YASARA to perform an energy minimization with each of the three acyl-
enzymes generated. These models of the mutants in the acyl-enzyme form with imi-
penem point to a systematic displacement of imipenem (between 0.9 and 1.4 Å of
the hydroxyethyl group compared to its position in the GES-1:imipenem acyl-enzyme
structure) away from the 170 position and concomitantly slightly away from E166
(Fig. 1d to f). The hydroxyethyl group in the a orientation on the C-6 carbon of the
carbapenem tested, instead of the b conformation characteristic of the other substit-
uent at this position in the penicillin and cephalosporin parts of this study, is known
to interfere with the catalytic water molecule activated by E166 during deacylation
(7). In GES-1, with a glycine at position 170, this water molecule is less constrained in
its catalytic position during the acylation because a path toward the solvent remains
accessible, while in the mutants tested in this study, this path is obstructed (Fig. 1g
and h). It is therefore possible that the displacement of the substrate combined with
the fencing by residue 170 restores a better positioning of the water molecule acti-
vated by E166 during hydrolysis, at least partially explaining the significant improve-
ment observed for the kcat values of the three mutants toward carbapenems. In the
GESG170H:imipenem model, an additional shift of the E166 side chain is observed.
More recent publications have demonstrated that substitutions at position 170 seem
to modify the distance between E166 and S70 residues by changing the position of
water molecule involved in the deacylation step (6, 7, 18). This was not observed in
our models, with only a 0.1-Å decrease (3.9-Å) of the E166-S70 distance in the
GESG170L and GESG170K models compared to GES-1 and a 0.9-Å increase (4.9-Å) in the
GESG170H model due to a slight rotation of the S70 hydroxyl. These effects do not pre-
clude an additional role for a potential modification of the X-loop dynamic like the
P174E substitutions (10). The improved kcat values of the three mutants for the carbape-
nems remain, however, significantly lower than the one reached by GES-1 against most
penicillins and cephalosporins. In conclusion, in this study we have showed how a single
mutation at position 170 in GES enzymes (i.e., G170H substitution) could develop the
ability to efficiently inactivate most of the b-lactams, including carbapenems, and to
resist to clavulanic acid. The combination of resistance to expanded-spectrum b-lactams,
carbapenems, and inhibitors makes some GES-producing bacteria very dangerous in clinical
settings.
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